Stock Analysis

$TSLA is melting up to $200 with the strong stock market. Tesla (TSLA) is a strong buy below $170 going forward if we see the chart break down.
 
Mosaic ($MOS) announced it has agreed to acquire Brazilian mining giant Vale’s fertilizer business for an aggregate purchase price valued at $2.5 billion.
 
Shares of Lennar ($LEN) may see early strength after the homebuilder reported fourth quarter results that exceeded analyst estimates.
 
Shares of Conatus Pharmaceuticals ($CNAT) are spiking higher in pre-market trading after the company announced a licensing agreement with Novartis ($NVS) for its liver disease treatment.
 
Biogen ($BIIB) announced the appointment of Michel Vounatsos as chief executive officer and a member of the Board of Directors, effective January 6, 2017. He will succeed George Scangos.
 
Used car retailer CarMax ($KMX) reported better than third quarter earnings but on revenues that came in just below analyst estimates.
 
After the close of trading on Tuesday, athletic apparel and footwear giant Nike ($NKE) reported second quarter results that exceeded analyst estimates.
 
Consulting firm Accenture ($ACN) reported better than expected second quarter earnings but on weaker than expected revenues.
 
FedEx ($FDX) reported second quarter earnings that rose-year-over-year but came in below expectations. The delivery giant reported revenues that slightly exceeded estimates.
 
Home goods retailer Bed Bath & Beyond ($BBBY) reported third quarter results that came in below analyst estimates and said full-year earnings are expected to come in at the low end of guidance.
 
Micron ($MU) reported better than expected first quarter earnings on revenues that came in line with estimates. The chipmaker also provided upbeat second quarter guidance.
 
$MRUS After a large deal this week, MRUS is trying to find a base near $20. Watch resistance in the $21's into next week.
 
Lockheed Martin ($LMT) may come under pressure after President-elect Donald Trump said he asked Boeing (BA) to price-out a comparable F-18 Super Hornet due to the tremendous cost and cost overruns of the Lockheed Martin F-35.
 
Synergy Pharmaceuticals ($SGYP) announced positive results in the second of two phase 3 trials of plecanatide in patients with irritable bowel syndrome with constipation
 
Cintas ($CTAS) reported second quarter earnings of $1.13 per share compared to analyst estimates for $1.15 per share. Revenue for the quarter rose 6.6 percent to $1.30 billion.
 
$MRUS After a large deal this week, MRUS is trying to find a base near $20. Watch resistance in the $21's into next week.
 
$TSLA is now testing the 200 day moving average located around $214. Tesla (TSLA) is a strong buy below $170 going forward if we see the chart break down.
 
Back
Top